DexCom, Inc.
NASDAQ:DXCMMedical - Devices
+$0.90 today
- Market cap
- $30.78B
- Beta
- 1.44
- P/E (TTM)
- 29.9
- EPS (TTM)
- $2.42
Volume 4.25M
Average 5.43M
DXCM Total Current Assets
All assets expected to be converted to cash or used up within one year.
DexCom, Inc.NASDAQ: DXCM
Total Current Assets · Q2 FY2026 · quarter ended Jun 2026
Total current assets falls 18.8% from a year ago
Total current assets stood at $4.09B at the end of Q2 FY2026, down 18.8% from a year earlier and down 5.7% from the prior quarter. Over 3 fiscal years it compounded at +3.2% a year.
Context
- Total current assets amounted to 63.3% of total assets at the end of Q2 FY2026, down 5.3 pp from a year earlier.
- Total current assets increased in 1 of the last 3 fiscal years.
What to watch
Whether total current assets keeps falling in the next quarterly balance sheet after a -18.8% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Current Assets history
USD · from the balance sheet
- Latest · FY2025
- 4.03B USD
- Year-over-year change
- -6.2%
- 4-year CAGR
- +2.3%
| Period | Period end | Total Current Assets | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 4.03B | -6.2% |
| FY2024 | 2024-12-31 | 4.3B | -2.8% |
| FY2023 | 2023-12-31 | 4.43B | +20.6% |
| FY2022 | 2022-12-31 | 3.67B | -0.4% |
| FY2021 | 2021-12-31 | 3.68B | — |
Total Current Assets vs competitors
How DXCM compares with its peers on the latest reported figures
- DXCM's Jun 2026 total current assets of $4.09B is the highest of the 7 companies compared; the peer median is $567.54M.
- Its year-over-year change of -18.8% is the 5th highest of 6, against a peer median of -5.3%.
- Total current assets amounts to 63.3% of total assets for DXCM, versus a peer median of 67.7%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $4.09B | -18.8% | +3.2% | 63.3% | |
| Jun 2026 | $1.85B | -18.1% | +13.3% | 58.4% | |
MMEDMiniMed Group, Inc. Common Stock | Jul 2026 | $1.42B | — | — | 30.0% |
| Mar 2026 | $887.1M | +33.7% | -10.1% | 76.9% | |
| Mar 2026 | $247.99M | -5.3% | +111.1% | 81.5% | |
| Mar 2026 | $92.28M | +17.7% | -10.0% | 89.7% | |
| Mar 2026 | $28.47M | -26.2% | -19.0% | 27.6% | |
MMEDVMiniMed Group, Inc. | — | — | — | — | — |
| Peer median (excluding DXCM) | $567.54M | -5.3% | -10.0% | 67.7% | |
Competitors are the stored peer set for DXCM. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 1.05B | 642.3M | 566.3M | 606.1M | 917.7M |
| Short-term Investments | 1.68B | 1.81B | 2.16B | 1.97B | 1.08B |
| Net Receivables | 516.6M | 752.2M | 987.5M | 1.03B | 1.29B |
| Inventory | 357.3M | 306.7M | 559.6M | 542.6M | 629.1M |
| Other Current Assets | 27.4M | 37M | 64.5M | 58.3M | 49.2M |
| Total Current Assets | 3.68B | 3.67B | 4.43B | 4.3B | 4.03B |
| Property, Plant & Equipment (Net) | 889.9M | 1.14B | 1.18B | 1.4B | 1.64B |
| Goodwill | 26.5M | 25.7M | 25.2M | 22.8M | 24.2M |
| Intangible Assets | 31.5M | 173.3M | 134.5M | 103.4M | 70.8M |
| Long-term Investments | 0 | 19M | 38.5M | 119.3M | 218M |
| Tax Assets | 290.5M | 341.2M | 419.4M | 481.2M | 295.6M |
| Other Non-current Assets | 10.5M | 28.1M | 36.5M | 53.7M | 60.7M |
| Total Non-current Assets | 1.25B | 1.72B | 1.84B | 2.18B | 2.31B |
| Total Assets | 4.93B | 5.39B | 6.26B | 6.48B | 6.34B |
| Account Payables | 189.4M | 237.9M | 276.4M | 345.3M | 344.3M |
| Short-term Debt | 0 | 772.6M | 0 | 1.2B | 0 |
| Tax Payables | 40.7M | 44.8M | 50.1M | 42.3M | 0 |
| Deferred Revenue | 2.1M | 10.1M | 18.4M | 8M | 7.7M |
| Other Current Liabilities | 48.4M | 47.7M | 46.4M | 56.1M | 54.6M |
| Total Current Liabilities | 720.8M | 1.84B | 1.56B | 2.93B | 2.14B |
| Long-term Debt | 1.98B | 1.2B | 2.43B | 1.24B | 1.24B |
| Deferred Tax Liabilities | 5.9M | 4.9M | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 16.1M | 19M | 7.4M | 9.5M | 0 |
| Other Non-current Liabilities | 11M | 44.8M | 59.6M | 79.9M | 83.3M |
| Total Non-current Liabilities | 2.17B | 1.42B | 2.64B | 1.45B | 1.45B |
| Total Liabilities | 2.89B | 3.26B | 4.2B | 4.38B | 3.59B |
| Common Stock | 400K | 400K | 400K | 400K | 400K |
| Retained Earnings | 138.7M | 479.9M | 1.02B | 1.6B | 2.43B |
| Accumulated OCI | 500K | (11.6M) | (16.7M) | (8M) | 115M |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 2.04B | 2.13B | 2.07B | 2.1B | 2.75B |
| Total Debt | 2.16B | 2.15B | 2.59B | 2.59B | 1.39B |
| Net Debt | 1.11B | 1.5B | 2.03B | 1.98B | 472M |
DexCom, Inc.
NASDAQ:DXCM
Intrinsic Alpha fair value
Locked
Current Price
$82.52
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.